Search results
Pay for Delay Is Sometimes Okay | JD Supra
JD Supra· 11 hours agoThe US Court of Appeals for the Second Circuit affirmed the dismissal of a lawsuit against pharmaceutical companies accused of violating antitrust laws by using reverse payments to delay entry ...
Big Pharma Teva Accused of Delaying Generic Drug Competition | Connecticut Law Tribune
Law.com· 2 days agoLawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to...
Hims & Hers debuts $199 weight-loss shots at 85% discount to Wegovy
Modern Healthcare· 4 days agoThis will help customers access these drugs without “navigating the shortages and costs that are currently limiting access to the branded medications,” Hims said in a press release. The new, ...
Does Mark Cuban still own the Mavericks? Billionaire explains why he sold NBA team to Adelson,...
Sporting News· 3 days agoMark Cuban has been a constant presence at Mavericks games throughout Dallas' playoff run, which comes as no surprise to anyone who has watched the franchise over the years. While many NBA owners ...
Hims debuts $199 weight-loss shots, takes aim at Lilly's Zepbound - Indianapolis Business Journal
Indianapolis Business Journal· 4 days agoIn just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to...
Hims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDA
NY Post via Yahoo Finance· 23 hours agoCompounding medications are commonly used when a patient is allergic to an ingredient in a...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 4 days agoActavis had spent that sum to acquire Forest and its portfolio of pharmaceutical products. Forest...
WHISTLEBLOWER ALLEGES GLAXOSMITHKLINE LIED ABOUT ZANTAC SAFETY CLAIMS
WFRV 5 Green Bay· 4 days agoPHILADELPHIA, May 20, 2024 /PRNewswire/ -- Valisure LLC, a technology company that conducts independent chemical analysis of pharmaceuticals, filed an amended complaint in ...
BioMarin (BMRN) Down 7.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 3 hours agoThe drug’s sales missed the Zacks Consensus ...fell 14% year over year to $105.6 million due to...
Viatris Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 days agoViatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-23. As...
